Cardiac rehabilitation after myocardial infarction - role, goals and effects
DOI:
https://doi.org/10.12775/JEHS.2023.43.01.003Keywords
cardiac rehabilitation, myocardial infarct, KOS-zawałAbstract
Cardiovascular diseases, in particular ischemic heart disease, are the leading cause of death worldwide. According to the current guidelines of scientific societies, the most important target group, in which preventive actions play a key role, are e.g. patients with ischemic heart disease.
The actions taken aimed at slowing down the progression of the disease, optimizing therapy, including its individualization, education and counseling in the field of pro-health behaviors. Preventive measures are also cost-effective in relation to the costs incurred for a number of measures taken in the event of an acute cardiovascular event. As a result, comprehensive care programs with secondary prevention as the primary objective are now considered the standard of care, particularly in patients with acute coronary artery disease (ACS).
References
World Health Organization (WHO). The World Health Report. WHO, 2019 (https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death)
ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J, 2021; 33: 3227-3337.
Jankowski P, Niewada M, Bochenek A, Bochenek-Klimczyk K, Bogucki M, Drygas W, Dudek D, Eysymontt Z, Grajek S, Kozierkiewicz A, 4. Mamcarz A, Olszowska M, Pająk A, Piotrowicz R, Podolec P, Wolszakiewicz J, Zdrojewski T, Zielińska D, Opolski G, Stępińska J. Optymalny Model Kompleksowej Rehabilitacji i Wtórnej Prewencji. Kardiologia Polska, 2013; 71(9): 995-1003.
Jankowski P, Gąsior M, Gierlotka M, Cegłowska U, Słomka M, Eysymontt Z, Gałaszek M, Buszman P, Kalarus Z, Kaźmierczak J, Legutko J, Sujkowska G, Matusewicz W, Opolski G, Hoffman P. Opieka koordynowana po zawale serca. Stanowisko Polskiego Towarzystwa Kardiologicznego oraz Agencji Technologii Medycznych i Taryfikacji. Kardiologia Polska, 2016, 74(8): 800-811
Kubielas G, Diakowska D, Uchmanowicz I. Survival analysis of patients with acute coronary syndrome receiving comprehensive coordinated care after myocardial infarction (KOS-Zawał). Kardiologia Polska, 2022; 80(3): 315-321
Sobieszek A, Milewski K. Koordynowana Opieka Specjalistyczna dla pacjenta po zawale serca-KOS-Zawał. Kardiologia Inwazyjna, 2017; 12(5): 4-6
Gąsior M, Wita K, Buszman P, Mizia-Stec K, Kalarus Z, Nowalany-Kozielska E, Sikora J, Wojakowski W, Gołba K, Milewski K, Pączek P, Cieśla D, Gąsior Z, Rozentryt P, Nessler J, Jankowski P, Niedziela J. Managed Care after Acute Myocardial Infarction (MC-AMI) improves prognosis in AMI survivors with pre-existing heart failure: A propensity score matching analysis of Polish nationwide program comprehensive post-MI care. Kardiologia Polska, 2022; 80(3): 302-306
Kolarczyk-Haczyk A, Konopko M, Mazur M, Żurakowski A, Gąsior M, Rogala M, Jankowski P, Kaźmierczak P, Milewski KP, Buszman PE, Buszman PP. Long-term outcomes of the Coordinated Care Program in Patients after Myocardial Infarction (KOS-MI). Kardiologia Polska, 2023;
Konopko M, Kolarczyk-Haczyk A, Mazur M, Kaźmierczak P, Żurakowski A, Gąsior M, Jankowski P, Buszman PE, Milewski K, Buszman PP. The Influence of Complete Revascularization and Comprehensive Cardiac Rehabilitation in Patients after Acute Myocardial Infarction (MI). Results from the Coordinated Care after MI Program in Poland. Journal of the American College of Cardiology, 2022; 79(9): 1593
https://www.stemlynsblog.org/b26-left-bundle-branch-block-lbbb/
https://medcases.io/blog-posty/ostre-zespoly-wiencowe
Massberg S, Polzin A. Update ESC-Leitlinie 2017: Duale Antiplättchentherapie [Update ESC-Guideline 2017: Dual Antiplatelet Therapy]. Dtsch Med Wochenschr. 2018 Aug;143(15):1090-1093. German. doi: 10.1055/a-0549-8230. Epub 2018 Jul 30. PMID: 30060279.
Scheen AJ. De l’athérosclérose à l’athérothrombose: D’une pathologie chronique silencieuse à un accident aigu critique [From atherosclerosis to atherothrombosis : from a silent chronic pathology to an acute critical event]. Rev Med Liege. 2018 May;73(5-6):224-228. French. PMID: 29926559.
Berg DD, Wiviott SD, Braunwald E, Guo J, Im K, Kashani A, Gibson CM, Cannon CP, Morrow DA, Bhatt DL, Mega JL, O'Donoghue ML, Antman EM, Newby LK, Sabatine MS, Giugliano RP. Modes and timing of death in 66 252 patients with non-ST-segment elevation acute coronary syndromes enrolled in 14 TIMI trials. Eur Heart J. 2018 Nov 7;39(42):3810-3820. doi: 10.1093/eurheartj/ehy556. PMID: 30239711; PMCID: PMC6220126.
Perk J, De Backer Guy, Gohlke H et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Car- diology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Kardiol Pol, 2012; 70 (suppl. I): S1–S100.
Généreux P, Campos CM, Yadav M et al. Reasonable incomplete revascularisation after percutaneous coronary intervention: the SYNTAX Revascularisation Index. EuroIntervention. 2015; 11: 634–642.
Piotrowicz E, Piotrowicz R. Cardiac telerehabilitation: current si- tuation and future challenges. Eur J Prev Cardiol, 2013; 20: 12–16.
Priori SG, Blomström-Lundqvist C, Mazzanti A et al. ESC Guideli- nes for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J, 2015; 36: 2793–2867.
ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J, 2011; 32: 1769–1818.
The Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and develo- ped in collaboration with the European Association for the Study of Diabetes (EASD). ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J, 2013; 34: 3035–3087.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Adriana Misiło, Krzysztof Olczyk, Monika Sosna, Krzysztof Mordoń
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 369
Number of citations: 0